“Bimekizumab Impact on Patient-Reported Outcomes in Patients With Moderate to Severe Hidradenitis Suppurativa: Pooled Week 48 Results from BE HEARD I&II”. 2024. SKIN The Journal of Cutaneous Medicine 8 (6): s476. https://doi.org/10.25251/skin.8.supp.476.